Status:
SUSPENDED
Study of Efficacy of Association of Senna Alexandrina Mill and Associations on Functional Intestinal Constipation
Lead Sponsor:
Marjan Industria e Comercio ltda
Conditions:
Constipation
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy of association of Senna alexandrina Mill (sena), Cassia fistula L., Tamarindus indica L., Coriandrum sativum L., Periandra mediterranea Taub. in p...
Detailed Description
This is a phase III trial, placebo-controlled with a parallel-group design.
Eligibility Criteria
Inclusion
- Patients between 18-65 years with functional constipation by ROME IIII criteria
- In the opinion of the investigator the patient will adhere to the protocol
- Voluntary able to understand the nature and purpose of the study, including the risks and adverse effects and with intent to cooperate with the researcher and act in accordance with the requirements of the entire protocol, which was confirmed by signing the Consent Informed
Exclusion
- hypersensitivity to any component
- pregnant or lactating
- abdominal pain of unknown etiology
- suspected intestinal occlusion and sub-occlusion
- suspected abdominal inflammatory conditions (as appendicitis, peritonitis, cystitis, endometritis)
- Crohn disease and colitis
- Suspected intestinal constipation due abdominal surgery, neurological disorders (as aganglionoses, Parkinson disease, medullar tumor, stroke, multiple sclerosis), systemic sclerosis, multiple myeloma, scleroderma
- Subjects with congenital mega colon, anorectal congenital malformation, inflammatory bowel disease or intestinal carcinoma
- history of mal-absorption diseases
- history of anemia, weight loss or anal bleeding
- history of hypothyroidism, hyperthyroidism and insulin-dependent diabetes mellitus
- known of positive result for human immunodeficiency virus test
- heart, liver, lung or kidney important condition
- drug or alcohol dependence
- knowledge or suspicion of malignancy
- body mass index \< 18
- body mass index \> 30
- participation on any experimental study 12 months prior this study
- familiar history of colon carcinoma or inflammatory disease
- Lack of adherence to the procedures of the protocol
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00990951
Start Date
June 1 2010
End Date
July 1 2014
Last Update
July 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departamento de Fisiologia e Farmacologia
Ceará, Fortaleza, Brazil